Status: current, Defined. Date: 31-Jan 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3131471000168111 | Plasma-Lyte 148 Replacement (magnesium chloride hexahydrate 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) injection, 1 x 1 L bag (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3131481000168114 | Plasma-Lyte 148 Replacement injection, 1 L bag | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Plasma-Lyte 148 Replacement injection, 1 L bag | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement injection, 1 L bag | Is a | Plasma-Lyte 148 Replacement injection, 1 L bag | true | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement injection, 1 L bag | has TPUU | Plasma-Lyte 148 Replacement injection, 1 L bag | true | Inferred relationship | Some | 1 | |
| Plasma-Lyte 148 Replacement injection, 1 L bag | has container type | bag | true | Inferred relationship | Some | ||
| Plasma-Lyte 148 Replacement injection, 1 L bag | has TP | Plasma-Lyte 148 Replacement | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR